A congressional committee heard complaints Tuesday against the owners of Purdue Pharma, the developer of OxyContin, as it mulled longshot legislation that would prevent them…
A congressional committee heard complaints Tuesday against the owners of Purdue Pharma, the developer of OxyContin, as it mulled longshot legislation that would prevent them…